OBJECTIVE	To determine the level of agreement and potential impact on disease-modifying antirheumatic drug ( DMARD ) escalation decisions and of adding musculoskeletal ultrasound ( MSUS ) assessment of disease activity to the Disease Activity Score in 28 joints ( DAS28 ) in early rheumatoid arthritis ( RA ) .\